• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高脂血症糖尿病小鼠降脂治疗可逆转肾损伤。

Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice.

机构信息

Department of Veterans Affairs, Lexington, KY, USA.

出版信息

J Lipid Res. 2010 Jun;51(6):1464-70. doi: 10.1194/jlr.M002972. Epub 2010 Jan 28.

DOI:10.1194/jlr.M002972
PMID:20110440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3035509/
Abstract

Hyperlipidemia is a risk factor for development and progression of diabetic nephropathy. However, it is not known if reduction of hyperlipidemia is protective against progression of disease. The goal of this study was to determine if reduction of hypercholesterolemia could limit progression of diabetic nephropathy. Diabetic and nondiabetic LDL receptor deficient (LDLR(-/-)) mice were fed diets containing either no cholesterol (0%) or high cholesterol (0.12%) for 36 weeks. One group each of diabetic and nondiabetic mice were fed the high-cholesterol diet for 26 weeks then changed to the 0% cholesterol diet for the last 10 weeks. Consumption of the high-cholesterol diet exacerbated the development of diabetic nephropathy with elevations in urine albumin excretion, glomerular and renal hypertrophy, and mesangial matrix expansion. Increased glomerular lipid and apolipoprotein B accumulation was found in diabetic mice that consumed the 0.12% cholesterol diet compared with other groups. However, diabetic mice that changed from the high-cholesterol diet to the 0% cholesterol diet for the last 10 weeks had lower urine albumin excretion and mesangial matrix expansion compared with mice that consumed the 0.12% cholesterol diet throughout. This suggests that hyperlipidemia causes continuous renal injury, and that lowering cholesterol levels by dietary means can improve renal function in diabetic LDLR(-/-) mice.

摘要

高脂血症是糖尿病肾病发展和进展的一个危险因素。然而,降低血脂是否能预防疾病进展尚不清楚。本研究的目的是确定降低高胆固醇血症是否能限制糖尿病肾病的进展。给予糖尿病和非糖尿病 LDL 受体缺陷(LDLR(-/-))小鼠含 0%或 0.12%胆固醇的饮食 36 周。每组各有一只糖尿病和非糖尿病小鼠先给予高胆固醇饮食 26 周,然后改为含 0%胆固醇饮食 10 周。高胆固醇饮食加重了糖尿病肾病的发展,表现为尿白蛋白排泄增加、肾小球和肾脏肥大以及系膜基质扩张。与其他组相比,给予 0.12%胆固醇饮食的糖尿病小鼠肾小球脂质和载脂蛋白 B 蓄积增加。然而,在最后 10 周从高胆固醇饮食改为 0%胆固醇饮食的糖尿病小鼠的尿白蛋白排泄和系膜基质扩张均低于持续给予 0.12%胆固醇饮食的小鼠。这表明高脂血症导致持续的肾脏损伤,通过饮食降低胆固醇水平可改善糖尿病 LDLR(-/-)小鼠的肾功能。

相似文献

1
Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice.高脂血症糖尿病小鼠降脂治疗可逆转肾损伤。
J Lipid Res. 2010 Jun;51(6):1464-70. doi: 10.1194/jlr.M002972. Epub 2010 Jan 28.
2
Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.糖基化终产物修饰的 biglycan 通过与整合素结合促进肾小球系膜细胞的迁移和增殖
Am J Pathol. 2011 Sep;179(3):1179-87. doi: 10.1016/j.ajpath.2011.05.016. Epub 2011 Jun 30.
3
Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice.高血糖和高血脂协同作用,诱导低密度脂蛋白受体缺陷的BALB小鼠发生肾脏疾病。
Am J Nephrol. 2004 Jan-Feb;24(1):20-31. doi: 10.1159/000075362. Epub 2003 Dec 10.
4
Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin.严重高甘油三酯血症和高胆固醇血症加速肾损伤:短期高脂/高胆固醇饮食和低剂量链脲佐菌素诱导的1型糖尿病仓鼠新模型
BMC Nephrol. 2015 Apr 11;16:51. doi: 10.1186/s12882-015-0041-5.
5
Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats.大米胚乳蛋白可减缓Zucker糖尿病肥胖大鼠的脂肪肝和糖尿病肾病进展。
Br J Nutr. 2016 Oct;116(8):1326-1335. doi: 10.1017/S0007114516003512. Epub 2016 Oct 11.
6
Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy.膳食大豆蛋白对降低II型糖尿病肾病患者血脂水平及改善肾功能的有益作用。
Eur J Clin Nutr. 2003 Oct;57(10):1292-4. doi: 10.1038/sj.ejcn.1601688.
7
Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.预防肾脏 apoB 滞留可预防糖尿病肾病:TGF-β 抑制的作用。
J Lipid Res. 2017 Dec;58(12):2264-2274. doi: 10.1194/jlr.M078204. Epub 2017 Sep 14.
8
Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus.在II型糖尿病动物模型中,膳食亚麻籽粉可降低蛋白尿并改善肾病。
Kidney Int. 2003 Dec;64(6):2100-7. doi: 10.1046/j.1523-1755.2003.00329.x.
9
Dietary low-fat soy milk powder retards diabetic nephropathy progression via inhibition of renal fibrosis and renal inflammation.膳食低脂豆浆粉通过抑制肾纤维化和肾炎症延缓糖尿病肾病进展。
Mol Nutr Food Res. 2017 Mar;61(3). doi: 10.1002/mnfr.201600461. Epub 2016 Nov 29.
10
Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse.新型过氧化物酶体增殖物激活受体 α 激动剂 CP-900691 对 BTBR ob/ob 小鼠糖尿病肾病的影响。
Lab Invest. 2014 Aug;94(8):851-62. doi: 10.1038/labinvest.2014.80. Epub 2014 Jun 23.

引用本文的文献

1
Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey.载脂蛋白 B 与肾功能:来自中国健康与营养调查的横断面研究。
Lipids Health Dis. 2020 May 27;19(1):110. doi: 10.1186/s12944-020-01241-7.
2
Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain.联合链脲佐菌素和单侧肾切除术是诱导“抗性”C57Bl/6J 小鼠实验性糖尿病肾病的有效方法。
Sci Rep. 2018 Apr 3;8(1):5542. doi: 10.1038/s41598-018-23839-9.
3
Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice.大软骨素蛋白聚糖缺乏小鼠循环 TGF-β 水平升高并不是动脉粥样硬化发展增加的原因。
Atherosclerosis. 2018 Jan;268:68-75. doi: 10.1016/j.atherosclerosis.2017.11.005. Epub 2017 Nov 10.
4
Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.预防肾脏 apoB 滞留可预防糖尿病肾病:TGF-β 抑制的作用。
J Lipid Res. 2017 Dec;58(12):2264-2274. doi: 10.1194/jlr.M078204. Epub 2017 Sep 14.
5
Early systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance.动脉粥样硬化性糖尿病猪早期的全身微血管损伤与肾血管生成素失衡同时出现。
PLoS One. 2015 Apr 24;10(4):e0121555. doi: 10.1371/journal.pone.0121555. eCollection 2015.
6
An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects.一种与糖尿病肾病有关的 ACACB 变体与肥胖人群的体重指数和基因表达相关。
PLoS One. 2013;8(2):e56193. doi: 10.1371/journal.pone.0056193. Epub 2013 Feb 27.
7
Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats.黄连素联合小剂量链脲佐菌素高脂饮食诱导的糖尿病大鼠的肾保护作用及其可能的分子机制。
Mol Biol Rep. 2013 Mar;40(3):2405-18. doi: 10.1007/s11033-012-2321-5. Epub 2012 Nov 30.
8
Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.糖基化终产物修饰的 biglycan 通过与整合素结合促进肾小球系膜细胞的迁移和增殖
Am J Pathol. 2011 Sep;179(3):1179-87. doi: 10.1016/j.ajpath.2011.05.016. Epub 2011 Jun 30.

本文引用的文献

1
Low density lipoproteins transactivate EGF receptor: role in mesangial cell proliferation.低密度脂蛋白激活表皮生长因子受体:在系膜细胞增殖中的作用。
Life Sci. 2008 Oct 24;83(17-18):595-601. doi: 10.1016/j.lfs.2008.08.010. Epub 2008 Sep 6.
2
Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway.普伐他汀通过抑制甲羟戊酸途径改善肾缺血再灌注损伤。
Kidney Int. 2008 Sep;74(5):577-84. doi: 10.1038/ki.2008.210. Epub 2008 May 28.
3
Effect of statins on the development of renal dysfunction.他汀类药物对肾功能障碍发展的影响。
Am J Cardiol. 2008 Apr 1;101(7):975-9. doi: 10.1016/j.amjcard.2007.11.042. Epub 2008 Jan 25.
4
Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.辛伐他汀对手术诱导的慢性肾衰竭载脂蛋白E缺陷小鼠的影响。
J Urol. 2008 Apr;179(4):1631-6. doi: 10.1016/j.juro.2007.11.042. Epub 2008 Mar 4.
5
Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development.血管紧张素II在动脉粥样硬化发展之前增加血管蛋白聚糖含量,并促进其发展。
J Lipid Res. 2008 Mar;49(3):521-30. doi: 10.1194/jlr.M700329-JLR200. Epub 2007 Nov 21.
6
Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.匹伐他汀通过下调db/db小鼠的NOX4改善蛋白尿和肾系膜扩张。
Kidney Int. 2007 Aug;72(4):473-80. doi: 10.1038/sj.ki.5002366. Epub 2007 Jun 13.
7
Mouse models for atherosclerosis and pharmaceutical modifiers.动脉粥样硬化的小鼠模型及药物修饰剂
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1706-21. doi: 10.1161/ATVBAHA.107.142570. Epub 2007 May 31.
8
Statins for improving renal outcomes: a meta-analysis.他汀类药物对改善肾脏结局的影响:一项荟萃分析。
J Am Soc Nephrol. 2006 Jul;17(7):2006-16. doi: 10.1681/ASN.2006010012. Epub 2006 Jun 8.
9
Dyslipidemia and the progression of renal disease in chronic renal failure patients.慢性肾衰竭患者的血脂异常与肾脏疾病进展
Kidney Int Suppl. 2005 Dec(99):S87-93. doi: 10.1111/j.1523-1755.2005.09916.x.
10
Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.近交系小鼠品系对糖尿病肾病易感性的特征分析
Diabetes. 2005 Sep;54(9):2628-37. doi: 10.2337/diabetes.54.9.2628.